Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 1/20 | 0.47 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.43 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 7/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | FASN | P49327 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25563224 | 0.93 | RAB9A (0.50) | IL17ADGAT1RAB9AL3MBTL1CYP1A2 | |
| SCHEMBL25570813 | 0.92 | MAPT (0.51) | IL17AKCNQ3KCNQ2DGAT1RAB9A | |
| SCHEMBL25563222 | 0.91 | IL17A (0.46) | IL17ADGAT1RAB9AL3MBTL1CYP1A2 | |
| SCHEMBL25562924 | 0.87 | KCNQ3 (0.39) | KCNQ3KCNQ2DGAT1RAB9AL3MBTL1 | |
| SCHEMBL25563213 | 0.85 | IL17A (0.42) | IL17AKCNQ3KCNQ2DGAT1RAB9A | |
| SCHEMBL25562988 | 0.81 | RAB9A (0.45) | DGAT1RAB9AL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL25569968 | 0.81 | IL17A (0.39) | IL17ADGAT1RAB9AL3MBTL1CYP1A2 | |
| SCHEMBL25563451 | 0.80 | MAPT (0.46) | KCNQ3KCNQ2DGAT1RAB9ACYP1A2 | |
| SCHEMBL25563014 | 0.80 | SYK (0.41) | DGAT1RAB9AL3MBTL1CYP1A2CYP2C19 | |
| SCHEMBL25563220 | 0.78 | IL17A (0.45) | IL17ARAB9AL3MBTL1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159465-A1 | IMMUNOMODULATOR | HITGEN INC. (CN) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159465-A1 | IMMUNOMODULATOR | IL2, IL17A, IL2RA | IL17A 2/4885KCNQ3 4772/4885KCNQ2 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.